MHIP Holdings
91 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | United States Treasury Bill 11/19/2026 | 15.68% | 243,300 | $242.2K |
| 2 | Eli Lilly & Co | 12.74% | 170 | $196.8K |
| 3 | State Street SPDR Portfolio S&P 500 ETF | 10.97% | 1,847 | $169.4K |
| 4 | BondBloxx Bloomberg Five Year Target Duration US Treasury ETF | 10.90% | 3,609 | $168.3K |
| 5 | BondBloxx Bloomberg Six Month Target Duration US Treasury ETF | 5.83% | 1,795 | $90.0K |
| 6 | AbbVie Inc | 4.66% | 270 | $72.0K |
| 7 | Johnson & Johnson | 3.96% | 240 | $61.1K |
| 8 | Amgen Inc | 2.95% | 113 | $45.5K |
| 9 | Thermo Fisher Scientific Inc | 2.55% | 60 | $39.4K |
| 10 | Gilead Sciences Inc | 2.35% | 252 | $36.3K |
| 11 | 4GLD US 11/19/26 C351.76 FLX | 1.77% | 8 | $27.4K |
| 12 | Intuitive Surgical Inc | 1.60% | 61 | $24.7K |
| 13 | Danaher Corp | 1.42% | 102 | $22.0K |
| 14 | Abbott Laboratories | 1.39% | 219 | $21.5K |
| 15 | Pfizer Inc | 1.35% | 759 | $20.9K |
| 16 | Stryker Corp | 1.19% | 66 | $18.4K |
| 17 | Bristol-Myers Squibb Co | 1.16% | 301 | $17.9K |
| 18 | Merck & Co Inc | 0.91% | 99 | $14.1K |
| 19 | McKesson Corp | 0.84% | 14 | $12.9K |
| 20 | Natera Inc | 0.78% | 30 | $12.0K |
| 21 | Boston Scientific Corp | 0.69% | 252 | $10.6K |
| 22 | Medtronic PLC | 0.62% | 110 | $9.6K |
| 23 | Illumina Inc | 0.57% | 32 | $8.8K |
| 24 | Medline Inc | 0.48% | 209 | $7.4K |
| 25 | IQVIA Holdings Inc | 0.47% | 28 | $7.3K |
Country Weights
- Other: 17.69%
- United States: 81.68%
- Ireland: 0.64%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.